This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Exprivia Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 3/6

Exprivia's earnings have been declining at an average annual rate of -8.9%, while the IT industry saw earnings growing at 20.3% annually. Revenues have been declining at an average rate of 24.9% per year. Exprivia's return on equity is 13.9%, and it has net margins of 6.7%.

Anahtar bilgiler

-8.9%

Kazanç büyüme oranı

-9.8%

EPS büyüme oranı

IT Sektör Büyümesi24.9%
Gelir büyüme oranı-24.9%
Özkaynak getirisi13.9%
Net Marj6.7%
Sonraki Kazanç Güncellemesi06 Aug 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Exprivia (BIT:XPR) Is Doing The Right Things To Multiply Its Share Price

Nov 18
Exprivia (BIT:XPR) Is Doing The Right Things To Multiply Its Share Price

Is It Time To Consider Buying Exprivia S.p.A. (BIT:XPR)?

Sep 23
Is It Time To Consider Buying Exprivia S.p.A. (BIT:XPR)?

A Look At The Intrinsic Value Of Exprivia S.p.A. (BIT:XPR)

Aug 30
A Look At The Intrinsic Value Of Exprivia S.p.A. (BIT:XPR)

Exprivia (BIT:XPR) Shareholders Will Want The ROCE Trajectory To Continue

Aug 10
Exprivia (BIT:XPR) Shareholders Will Want The ROCE Trajectory To Continue

What Is Exprivia S.p.A.'s (BIT:XPR) Share Price Doing?

Jun 14
What Is Exprivia S.p.A.'s (BIT:XPR) Share Price Doing?

Exprivia S.p.A.'s (BIT:XPR) Price Is Right But Growth Is Lacking After Shares Rocket 28%

Apr 04
Exprivia S.p.A.'s (BIT:XPR) Price Is Right But Growth Is Lacking After Shares Rocket 28%

Does Exprivia (BIT:XPR) Have A Healthy Balance Sheet?

Mar 01
Does Exprivia (BIT:XPR) Have A Healthy Balance Sheet?

Exprivia (BIT:XPR) Is Looking To Continue Growing Its Returns On Capital

Feb 02
Exprivia (BIT:XPR) Is Looking To Continue Growing Its Returns On Capital

Does Exprivia (BIT:XPR) Have A Healthy Balance Sheet?

Nov 11
Does Exprivia (BIT:XPR) Have A Healthy Balance Sheet?

Exprivia (BIT:XPR) Takes On Some Risk With Its Use Of Debt

Jul 08
Exprivia (BIT:XPR) Takes On Some Risk With Its Use Of Debt

Should You Investigate Exprivia S.p.A. (BIT:XPR) At €1.32?

Jun 10
Should You Investigate Exprivia S.p.A. (BIT:XPR) At €1.32?

Gelir ve Gider Dağılımı

Exprivia nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

BIT:XPR Gelir, gider ve kazançlar (EUR Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
31 Dec 231971300
30 Sep 231951300
30 Jun 231861200
31 Mar 231831200
31 Dec 221781200
30 Sep 221871100
30 Jun 221841100
31 Mar 221811100
31 Dec 211791000
30 Sep 211701000
30 Jun 21168900
31 Mar 21166800
31 Dec 20164900
30 Sep 20-9916400
30 Jun 20-57800
31 Mar 20987700
31 Dec 191657010
30 Sep 19567-82-50
30 Jun 19579440
31 Mar 19607860
31 Dec 18615000
30 Sep 18473-590
30 Jun 18367-750
31 Mar 18235-1240
31 Dec 17160040
30 Sep 17153-140
30 Jun 17148240
31 Mar 17144440
31 Dec 16140340
30 Sep 16139540
30 Jun 16137470
31 Mar 16139440
31 Dec 15141540
30 Sep 15146450
30 Jun 15148410
31 Mar 15147440
31 Dec 14144450
30 Sep 14137350
30 Jun 14135350
31 Mar 14130250
31 Dec 13128250
30 Sep 13131360

Kaliteli Kazançlar: XPR has high quality earnings.

Büyüyen Kar Marjı: XPR's current net profit margins (6.7%) are higher than last year (6.5%).


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: XPR şirketinin kazancı son 5 yılda yıllık 8.9% azaldı.

Büyüme Hızlandırma: XPR's earnings growth over the past year (13.9%) exceeds its 5-year average (-8.9% per year).

Kazançlar vs. Sektör: XPR earnings growth over the past year (13.9%) did not outperform the IT industry 26%.


Özkaynak Getirisi

Yüksek ROE: XPR's Return on Equity (13.9%) is considered low.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin